NCT00300742View on ClinicalTrials.gov

Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Alcohol DependenceBinge Eating
Interventions
DRUG

Topiramate

Topiramate up to 300 mg per day.

Trial Locations (2)

22911

UVA CARE, Charlottesville

23294

UVA CARE Richmond, Richmond

All Listed Sponsors
lead

University of Virginia

OTHER

NCT00300742 - Topiramate for the Treatment of Alcohol Dependent Binge-Eating Disordered Individuals | Biotech Hunter | Biotech Hunter